Literature DB >> 14984171

Congenital toxoplasmosis in Uberlândia, MG, Brazil.

Gesmar Rodrigues Silva Segundo1, Deise Aparecida Oliveira Silva, José Roberto Mineo, Marcelo Simão Ferreira.   

Abstract

Almost all babies suffering from congenital toxoplasmosis, if undiagnosed and untreated, will develop visual or neurological impairments by adulthood. The aim of this study was to investigate the occurrence of congenital toxoplasmosis in two hospitals from Uberlândia, Brazil. A total of 805 serum samples of cord blood were collected, 500 from public hospital and 305 from private hospital, and all patients answered a questionnaire about pregnancy and newborns. ELISA was accomplished to detect IgG antibodies to Toxoplasma gondii and positive sera were re-tested to verify specific IgM and IgA antibodies in a capture ELISA. Seroprevalence of IgG antibodies against T. gondii was 51.6 per cent in the hospitals, while the frequency of congenital toxoplasmosis was 0.5 per cent, with specific IgM and/or IgA antibodies. The main clinical alteration was chorioretinitis (an inflammatory process of the retina and uveal tract). The high seroprevalence in this population and expressive rate of congenital disease show the requirement of screening programmes for toxoplasmosis during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984171     DOI: 10.1093/tropej/50.1.50

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  6 in total

1.  Seroprevalence and sources of toxoplasmosis among Orang Asli (indigenous) communities in Peninsular Malaysia.

Authors:  Romano Ngui; Yvonne A L Lim; Noor Farah Hani Amir; Veeranoot Nissapatorn; Rohela Mahmud
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  Prematurity and Low Birth Weight did not Correlate with Anti-Toxoplasma gondii Maternal Serum Profiles--a Brazilian Report.

Authors:  Mariana Machado Lemos Fochi; Sabrina Baring; Lígia Cosentino Junqueira Franco Spegiorin; Denise Cristina Mós Vaz-Oliani; Eloisa Aparecida Galão; Antonio Hélio Oliani; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

3.  Comparative Detection of Immunoglobulin Isotypes and Subclasses against Toxoplasma gondii Soluble Antigen in Serum and Colostrum Samples from Puerperal Women.

Authors:  Hellen Dayane Silva Borges; Ana Carolina Morais Oliveira-Scussel; Ângela Maria Morais Oliveira; Vânia Olivetti Steffen Abdallah; Ana Cláudia Arantes Marquez Pajuaba; José Roberto Mineo
Journal:  Int J Environ Res Public Health       Date:  2022-06-29       Impact factor: 4.614

4.  Association of gestational diabetes mellitus and negative modulation of the specific humoral and cellular immune response against Toxoplasma gondii.

Authors:  Ana Carolina de Morais Oliveira-Scussel; Paula Tatiana Mutão Ferreira; Renata de Souza Resende; Cristhianne Molinero Ratkevicius-Andrade; Angelica de Oliveira Gomes; Marina Carvalho Paschoini; Fernanda Bernadelli De Vito; Thaís Soares Farnesi-de-Assunção; Marcos Vinícius da Silva; José Roberto Mineo; Denise Bertulucci Rocha Rodrigues; Virmondes Rodrigues
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

5.  Congenital toxoplasmosis in a reference center of Paraná, Southern Brazil.

Authors:  Jaqueline Dario Capobiango; Regina Mitsuka Breganó; Italmar Teodorico Navarro; Claudio Pereira Rezende Neto; Antônio Marcelo Barbante Casella; Fabiana Maria Ruiz Lopes Mori; Sthefany Pagliari; Inácio Teruo Inoue; Edna Maria Vissoci Reiche
Journal:  Braz J Infect Dis       Date:  2014-03-22       Impact factor: 3.257

6.  Gestational toxoplasmosis in Paraná State, Brazil: prevalence of IgG antibodies and associated risk factors.

Authors:  Fabiana Maria Ruiz Lopes-Mori; Regina Mitsuka-Breganó; Laura Helena França de Barros Bittencourt; Renata Cristina Ferreira Dias; Daniela Dib Gonçalves; Jaqueline Dario Capobiango; Edna Maria Vissoci Reiche; Helena Kaminami Morimoto; Roberta Lemos Freire; Italmar Teodorico Navarro
Journal:  Braz J Infect Dis       Date:  2013-05-09       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.